Cargando…

Respiratory Syncytial Virus Infection in Children with Neuromuscular Impairment

Clinically obvious reasons why children with neurological impairment (NMI) may be more severely affected in case of a viral respiratory tract infection include reduced vital capacity due to muscular weakness or spastic scoliosis, disturbed clearance of respiratory excretions (weak coughing and dysph...

Descripción completa

Detalles Bibliográficos
Autores principales: Simon, Arne, Prusseit, Julia, Müller, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Open 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258658/
https://www.ncbi.nlm.nih.gov/pubmed/22262988
http://dx.doi.org/10.2174/1874285801105010155
_version_ 1782221288478081024
author Simon, Arne
Prusseit, Julia
Müller, Andreas
author_facet Simon, Arne
Prusseit, Julia
Müller, Andreas
author_sort Simon, Arne
collection PubMed
description Clinically obvious reasons why children with neurological impairment (NMI) may be more severely affected in case of a viral respiratory tract infection include reduced vital capacity due to muscular weakness or spastic scoliosis, disturbed clearance of respiratory excretions (weak coughing and dysphagia), inability to comply actively with physiotherapeutic interventions, recurrent micro-aspirations (gastroesophageal reflux disease, vomiting related to coughing), a history of frequent exposure to antibiotics and health care institutions, colonization with resistant pathogens, impaired immunologic defence mechanisms due to severe malnutrition and cachexia, and early clinical deterioration in case of high fever with metabolic acidosis and hypercapnia, and maybe associated seizures or febrile convulsions. Data from the literature suggests that in all children with NMI, who have to be hospitalized with severe clinical deterioration due to an airway infection, at least one specimen of nasopharyngeal secretions should be sent as soon as possible to a virologic laboratory to detect viral pathogens. Children with severe NMI and those mechanically ventilated for other reasons being hospitalized during the RSV season must be strictly protected against nosocomial RSV infection by means of standard and droplet precautions. Finally, children with severe NMI and age below 24 months of life should receive passive immunization with palivizumab following international recommendations.
format Online
Article
Text
id pubmed-3258658
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Bentham Open
record_format MEDLINE/PubMed
spelling pubmed-32586582012-01-19 Respiratory Syncytial Virus Infection in Children with Neuromuscular Impairment Simon, Arne Prusseit, Julia Müller, Andreas Open Microbiol J Article Clinically obvious reasons why children with neurological impairment (NMI) may be more severely affected in case of a viral respiratory tract infection include reduced vital capacity due to muscular weakness or spastic scoliosis, disturbed clearance of respiratory excretions (weak coughing and dysphagia), inability to comply actively with physiotherapeutic interventions, recurrent micro-aspirations (gastroesophageal reflux disease, vomiting related to coughing), a history of frequent exposure to antibiotics and health care institutions, colonization with resistant pathogens, impaired immunologic defence mechanisms due to severe malnutrition and cachexia, and early clinical deterioration in case of high fever with metabolic acidosis and hypercapnia, and maybe associated seizures or febrile convulsions. Data from the literature suggests that in all children with NMI, who have to be hospitalized with severe clinical deterioration due to an airway infection, at least one specimen of nasopharyngeal secretions should be sent as soon as possible to a virologic laboratory to detect viral pathogens. Children with severe NMI and those mechanically ventilated for other reasons being hospitalized during the RSV season must be strictly protected against nosocomial RSV infection by means of standard and droplet precautions. Finally, children with severe NMI and age below 24 months of life should receive passive immunization with palivizumab following international recommendations. Bentham Open 2011-12-30 /pmc/articles/PMC3258658/ /pubmed/22262988 http://dx.doi.org/10.2174/1874285801105010155 Text en © Simon et al.; Licensee Bentham Open. http://creativecommons.org/licenses/by-nc/3.0/ This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
spellingShingle Article
Simon, Arne
Prusseit, Julia
Müller, Andreas
Respiratory Syncytial Virus Infection in Children with Neuromuscular Impairment
title Respiratory Syncytial Virus Infection in Children with Neuromuscular Impairment
title_full Respiratory Syncytial Virus Infection in Children with Neuromuscular Impairment
title_fullStr Respiratory Syncytial Virus Infection in Children with Neuromuscular Impairment
title_full_unstemmed Respiratory Syncytial Virus Infection in Children with Neuromuscular Impairment
title_short Respiratory Syncytial Virus Infection in Children with Neuromuscular Impairment
title_sort respiratory syncytial virus infection in children with neuromuscular impairment
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258658/
https://www.ncbi.nlm.nih.gov/pubmed/22262988
http://dx.doi.org/10.2174/1874285801105010155
work_keys_str_mv AT simonarne respiratorysyncytialvirusinfectioninchildrenwithneuromuscularimpairment
AT prusseitjulia respiratorysyncytialvirusinfectioninchildrenwithneuromuscularimpairment
AT mullerandreas respiratorysyncytialvirusinfectioninchildrenwithneuromuscularimpairment